Friday, May 1, 2026
Egypt News Club
No Result
View All Result
SUBMIT NEWS
  • HOME
  • HOME
No Result
View All Result
Egypt News Club
Submit News
Home PRESS RELEASES

Allergy Immunotherapy Market size to Reach USD 3.72 Billion by 2031, Supported by SLIT Expansion, Pediatric Label Approvals, and Value-Based Care Adoption

NEWSROOM by NEWSROOM
March 6, 2026
in PRESS RELEASES
Share on FacebookShare on Twitter


Mordor Intelligence has published a new report on the allergy immunotherapy market, offering a comprehensive analysis of trends, growth drivers, and future projections. 

Allergy Immunotherapy Market Overview  

According to Mordor Intelligence, the allergy immunotherapy market size is projected to grow from USD 2.67 billion in 2026 to USD 3.72 billion by 2031, registering a CAGR of 6.85% during the forecast period. The expansion of disease-modifying therapies, increasing regulatory approvals for sublingual immunotherapy tablets, and integration into value-based care models are shaping the allergy immunotherapy market growth trajectory. 

Unlike symptomatic treatments that provide temporary relief, immunotherapy aims to modify the underlying allergic response. This shift toward long-term disease control is central to the rising allergy immunotherapy market size. Expanding pediatric indications and broader insurance coverage are also widening the addressable patient pool, strengthening the allergy immunotherapy market forecast across developed healthcare systems. 

Key Allergy Immunotherapy Market Trends Influencing Industry Direction 

Rising Burden of Respiratory and Food Allergies 

One of the defining allergy immunotherapy market trends is the growing prevalence of allergic rhinitis, food allergies, and asthma. Urbanization, environmental exposure, and lifestyle factors are contributing to higher diagnosis rates. The economic burden of allergies, including healthcare spending and productivity losses, is encouraging payers to support disease-modifying therapies. 

Regulatory Expansion of SLIT Tablets 

Recent regulatory approvals for sublingual immunotherapy tablets in pediatric and adult populations are reshaping the allergy immunotherapy market. Tablet formulations are gaining preference due to standardized dosing and ease of home administration. 

Integration into Value-Based Care Models 

Inclusion of allergy immunotherapy within value-based reimbursement contracts is another important allergy immunotherapy market trend. Insurers are increasingly aligning payments with outcomes such as reduced emergency visits and improved symptom control. 

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/allergy-immunotherapy-market?utm_source=emailwire  

Allergy Immunotherapy Market Segmentation Analysis 

By Immunotherapy Type 

  • Subcutaneous Immunotherapy 
  • Sublingual Immunotherapy 

By Allergy Type 

By Formulation 

By Distribution Channel 

  • Direct-To-Physician Sales 
  • Retail and Hospital Pharmacies 
  • E-Commerce and Mail-Order Channels 

By Geography 

Explore Our Full Library of Healthcare Research Report:  https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=emailwire  

Competitive Landscape of the Allergy Immunotherapy Market 

The allergy immunotherapy industry shows moderate concentration, with established companies leading the tablet and extract segments. Competitive strategies focus on expanding pediatric indications, entering new geographic markets, and integrating digital tools to enhance adherence. 

Key Players in the Allergy Immunotherapy Market 

  • Allergy Therapeutics plc 
  • Torii Pharmaceutical Co., Ltd. 

Explore more insights on allergy immunotherapy competitive landscape: https://www.mordorintelligence.com/industry-reports/allergy-immunotherapy-market/companies?utm_source=emailwire  

Conclusion 

The allergy immunotherapy market is positioned for sustained expansion through the forecast period. The shift from short-term symptom management to long-term disease modification is reinforcing the structural foundation of the allergy immunotherapy industry. 

Regulatory approvals for sublingual tablets, broader pediatric indications, and integration into value-based care contracts are strengthening the allergy immunotherapy market forecast. At the same time, digital health platforms and mail-order distribution are improving treatment adherence and widening patient access. 

While diagnosis gaps and limited specialist availability constrain adoption in certain regions, established markets continue to demonstrate consistent allergy immunotherapy market growth. As reimbursement support aligns with clinical evidence, the allergy immunotherapy market size is expected to expand steadily, maintaining balanced allergy immunotherapy market share across therapy types and geographic regions. 

Get detailed insights on the allergy immunotherapy market:  

https://www.mordorintelligence.com/industry-reports/allergy-immunotherapy-market?utm_source=emailwire  

Industry Related Reports 

Allergy Relieving Eye Drops Market: 

The allergy relieving eye drops market is segmented by drug class, type of allergic conjunctivitis, and geography, driven by rising allergy prevalence, increasing OTC product adoption, and growing awareness of ocular allergy management. 

Get more insights:  https://www.mordorintelligence.com/industry-reports/allergy-relieving-eye-drops?utm_source=emailwire 

Gluten Intolerance Treatment Market size: 

The gluten intolerance treatment market was valued at USD 7.3 billion in 2025 and is projected to reach USD 10.1 billion by 2030, growing at a CAGR of 8.3%, supported by rising diagnosis rates and increasing adoption of therapeutic and dietary management solutions. 

Get more insights:  https://www.mordorintelligence.com/industry-reports/gluten-intolerance-treatment-market?utm_source=emailwire 

Allergy Treatment Market share: 

The allergy treatment market is expected to grow from USD 24.49 billion in 2026 to USD 35.28 billion by 2031, registering a CAGR of 7.58%, driven by increasing global allergy burden, expanding biologics adoption, and advancements in immunotherapy options. 

Get more insights:  https://www.mordorintelligence.com/industry-reports/allergy-treatment-market?utm_source=emailwire 

About Mordor Intelligence: 

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. 

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. 

For any inquiries or to access the full report, please contact: 

media@mordorintelligence.com
https://www.mordorintelligence.com/ 



Source link

Tags: Allergy Immunotherapy Market GrowthAllergy Immunotherapy Market ShareAllergy Immunotherapy Market Size
Previous Post

Hair Styling Tools Market Size to Reach USD 17.32 Billion by 2031 with Rising At-Home Grooming Trends

Next Post

Disposable Medical Gloves Market Size to Reach USD 18.81 Billion by 2031, Driven by Rising Infection Control Protocols and Expanding Healthcare Access

Related News

$1.1 Trillion by 2035 — How Digital Platforms Are Revolutionizing Travel Booking and Planning

by NEWSROOM
April 30, 2026

Online Travel | OTA | Travel Booking | Regional Breakdown | April 2026 | Source: MRFR Online Travel Market Key Takeaways...

$45 Billion by 2035 — How Cloud-Connected Robots Are Powering the Automation Revolution

by NEWSROOM
April 30, 2026

Cloud Robotics | Robot as a Service | Connected Automation | Regional Breakdown | April 2026 | Source: WGR Cloud Robotics...

$65.4 Billion by 2035 — How Cloud-Native WAF Is Protecting Modern Web Applications

by NEWSROOM
April 30, 2026

Web Application Firewall | WAF | Application Security | Regional Breakdown | April 2026 | Source: MRFR Web Application Firewall Market...

$30.5 Billion by 2035 — How Technology Is Revolutionizing Real Estate Transactions and Management

by NEWSROOM
April 30, 2026

Property Technology | PropTech | Real Estate Tech | Regional Breakdown | April 2026 | Source: WGR PropTech Market Key Takeaways...

Next Post

Workforce Management Market is Expected to Reach USD 20.03 Billion by 2035 | CAGR of 8.01%

Procurement Software Market is Set to Grow USD 18.47 Billion by 2035 | CAGR of 9.49%

Trending News

BingX Launches Zero-Fee Carnival for Spot Trading on Crypto & TradFi Assets

March 4, 2026

OmanNews.Club™ Adds to Arab Newswire Media Lists for Press Release Distribution to GCC/MENA Countries

August 14, 2022

ZainTech partners with LigaData to deliver data-driven digital services in MENA

June 16, 2022

About

EgyptNews.Club™ gathers and publishes business, cultural, socio-economic, Tech and industrial news on Egypt, Middle East and North Africa (MENA).

Press release distribution services:
We provide press release distribution to media in Egypt, the Arab world and the GCC/MENA regions. Submit a press release today or contact us.

Share Us

Category

BUSINESS
ENTERTAINMENT
FASHION
FOOD
HEALTH
LIFESTYLE

SPORTS
TRAVEL
AFRICA
MIDDLE EAST
PRESS RELEASES

Newsletter

    Recent News

    EgyptNews.Club™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC

    About Us / Contact Us / Submit News

    No Result
    View All Result
    • HOME

    EgyptNews.Club™ is part of GroupWeb Media Network. © May, 2026 GroupWeb Media LLC